US · Healthcare

Frontage Holdings Corporation (FGHQF)

Biotechnology

Frontage Holdings Corporation (FGHQF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for FGHQF

P/E ratio

25.00

Frontage Holdings Corporation (FGHQF) — FAQ

What is FGHQF's P/E ratio?

The price-to-earnings (P/E) ratio for Frontage Holdings Corporation (FGHQF) is 25.00 (data as of 2026-05-23).

Does Frontage Holdings Corporation pay a dividend?

Dividend yield is not available in the current snapshot for Frontage Holdings Corporation (FGHQF). Check the MyAverix Finance app for the latest dividend data.

What sector is Frontage Holdings Corporation in?

Frontage Holdings Corporation (FGHQF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is FGHQF listed on?

FGHQF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)